Evidence map›Paper›PMID 34938352›Full record

Trial reportComputational and mathematical methods in medicine2021

Nanosilver Dressing in Treating Deep II Degree Burn Wound Infection in Patients with Clinical Studies.

Bin'e Wu, Fengchun Zhang, Wenbin Jiang, Aiyan Zhao

RetractedOpen access · hybridAbstract readRandomized Controlled TrialRetracted Publication
In one paragraph

Trial report in Computational and mathematical methods in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Wound Dressing Modifications for Accelerated Healing of Infected Wounds.International journal of molecular sciences · 2023
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Bin'e WuDepartment of Disinfection and Supply, Weifang People's Hospital, Weifang, China.
Fengchun ZhangDepartment of Disinfection and Supply, Weifang People's Hospital, Weifang, China.
Wenbin JiangDepartment of Disinfection and Supply, Weifang People's Hospital, Weifang, China.
Aiyan ZhaoDepartment of Disinfection and Supply, Weifang People's Hospital, Weifang, China.ORCID https://orcid.org/0000-0002-1958-5358
Weifang People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients' clinical antibiotic treatment of deep II degree burns usually fails to achieve the ideal effect; in order to avoid the late result in pigmentation, scarring, and even limb dysfunction, it also needs to deal effectively with burn wounds.

aimThe purpose of this study is to evaluate nanosilver dressing in treating deep II degree burn wound infection in patients with clinical studies. MATERIALS AND

methods106 burn patients were classified into the Sulfadiazine Silver Cream (SSC) group (

resultsAfter basic treatment for all patients, Sulfadiazine Silver Cream was used in the SSC group, and Nanosilver Burn Dressing was used in the NSBD group. It was observed that after treatment, compared with the SSC group, there was significant efficiency; wound healing rate, healing time, and pigmentation fading away time were shortened in the NSBD group, and IL-1

conclusionNanosilver Burn Dressing in treating deep II degree burns can effectively reduce the wound infection and promote wound healing. The curative effect was distinct, which was worthy of popularization and application.

Indexed as

BandagesAdultAnti-Infective Agents, LocalBurnsComputational BiologyFemaleHumansMaleMetal NanoparticlesSilverSilver SulfadiazineTime FactorsTreatment OutcomeWound HealingWound InfectionAnti-Infective Agents, LocalSilverSilver Sulfadiazine

Identifiers

PMID34938352
PMCPMC8687789
OpenAlexW4200331522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.